help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published online as doi:10.2353/ajpath.2008.080391 on November 6, 2008

Published online before print November 6, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2008.080391v1
173/6/1628    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berkowitz, P.
Right arrow Articles by Rubenstein, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berkowitz, P.
Right arrow Articles by Rubenstein, D. S.
(American Journal of Pathology. 2008;173:1628-1636.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.080391

Autoantibodies in the Autoimmune Disease Pemphigus Foliaceus Induce Blistering via p38 Mitogen-Activated Protein Kinase-Dependent Signaling in the Skin

Paula Berkowitz*, Michael Chua{dagger}, Zhi Liu*, Luis A. Diaz* and David S. Rubenstein*{ddagger}

From the Departments of Dermatology* and Cell and Molecular Physiology{dagger} and the Lineberger Comprehensive Cancer Center,{ddagger} University of North Carolina, Chapel Hill, North Carolina

Pemphigus foliaceus (PF) is a human autoimmune blistering disease in which a humoral immune response targeting the skin results in a loss of keratinocyte cell-cell adhesion in the superficial layers of the epidermal epithelium. In PF, desmoglein-1-specific autoantibodies induce blistering. Evidence is beginning to accumulate that activation of signaling may have an important role in the ability of pathogenic pemphigus IgGs to induce blistering and that both p38 mitogen-activated protein kinase (MAPK) and heat shock protein (HSP) 27 are part of this signaling pathway. This study was undertaken to investigate the ability of PF IgGs to activate signaling as well as the contribution of this signaling pathway to blister induction in an in vivo model of PF. Phosphorylation of both p38 MAPK and HSP25, the murine HSP27 homolog, was observed in the skin of PF IgG-treated mice. Furthermore, inhibition of p38 MAPK blocked the ability of PF IgGs to induce blistering in vivo. These results indicate that PF IgG-induced blistering is dependent on activation of p38 MAPK in the target keratinocyte. Rather than influencing the immune system, limiting the autoantibody-induced intracellular signaling response that leads to target end-organ damage may be a more viable therapeutic strategy for the treatment of autoimmune diseases. Inhibition of p38 MAPK may be an effective strategy for the treatment of PF.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
V. Spindler, W.-M. Heupel, A. Efthymiadis, E. Schmidt, R. Eming, C. Rankl, P. Hinterdorfer, T. Muller, D. Drenckhahn, and J. Waschke
Desmocollin 3-mediated Binding Is Crucial for Keratinocyte Cohesion and Is Impaired in Pemphigus
J. Biol. Chem., October 30, 2009; 284(44): 30556 - 30564.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb. Perspect. Biol.Home page
E. Delva, D. K. Tucker, and A. P. Kowalczyk
The desmosome.
Cold Spring Harb Perspect Biol, August 1, 2009; 1(2): a002543 - a002543.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. E. Lee, P. Berkowitz, P. S. Jolly, L. A. Diaz, M. P. Chua, and D. S. Rubenstein
Biphasic Activation of p38MAPK Suggests That Apoptosis Is a Downstream Event in Pemphigus Acantholysis
J. Biol. Chem., May 1, 2009; 284(18): 12524 - 12532.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.